Susan Dallas-Feeney, DO
Family Medicine · West Chester, PANPI 1922187277
Payments from drug & device makers
Across 300 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$937
- Novo Nordisk$803
- Amgen$643
- AstraZeneca$513
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$355
- Lilly USA, LLC$320
- plus $1K from 27 others
What the payments were for
- Food & beverage$4,92598%
- Education$1162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $937 |
| Novo Nordisk | 48 | $803 |
| Amgen | 42 | $643 |
| AstraZeneca | 31 | $513 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $355 |
| Lilly USA, LLC | 19 | $320 |
| Pfizer | 11 | $200 |
| GSK | 11 | $178 |
| Astellas Pharma US Inc | 3 | $133 |
| Bausch Health US, LLC | 8 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $116 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $71 |
| IBSA Pharma Inc. | 4 | $59 |
| Exact Sciences | 3 | $55 |
| Amneal Pharmaceuticals LLC | 2 | $49 |
| Boehringer Ingelheim | 3 | $42 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| Genentech USA, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Eisai Inc. | 1 | $32 |
| Dexcom, Inc. | 1 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Radius Health, Inc. | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Acella Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
How this compares
$5,041 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 65 | $86,543 |
| MounjaroTirzepatide | 49 | $61,597 |
| EliquisApixaban | 18 | $18,277 |
| JardianceEmpagliflozin | 11 | $14,841 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $13,628 |
| FarxigaDapagliflozin Propanediol | 12 | $11,608 |
| TrulicityDulaglutide | 13 | $10,981 |
| SynthroidLevothyroxine Sodium | 57 | $7,890 |
| Repatha SureclickEvolocumab | 11 | $7,179 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 17 | $6,616 |
| Rosuvastatin Calcium | 249 | $5,929 |
| Armour ThyroidThyroid,pork | 27 | $3,247 |
| TirosintLevothyroxine Sodium | 16 | $3,163 |
| Pulmicort FlexhalerBudesonide | 12 | $2,990 |
| ValacyclovirValacyclovir Hcl | 42 | $2,018 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $803 | $86,54365 claims |
| Lilly USA, LLCMounjaro, Trulicity | $320 | $72,57962 claims |
| PfizerEliquis | $200 | $18,27718 claims |
| Boehringer IngelheimJardiance | $42 | $14,84111 claims |
| AstraZenecaFarxiga, Pulmicort Flexhaler | $513 | $14,59824 claims |
| GSKTrelegy Ellipta | $178 | $13,62816 claims |
| AbbVieSynthroid, Armour Thyroid | $937 | $11,13784 claims |
| Arbor Pharmaceuticals, Inc.Edarbyclor | $27 | $6,61617 claims |
| IBSA Pharma Inc.Tirosint | $59 | $3,16316 claims |
| Amneal Pharmaceuticals LLCUnithroid | $49 | $1,11269 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in West Chester
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.